[Treatment strategies for neonatal pulmonary morbidity in Europe]

L Desnoulez1, J Empana, M Anceschi

  • 1Service de médecine néonatale, hôpital Jeanne-de-Flandre, 59037 Lille, France. l-desnoulez@chru-lille.fr <l-desnoulez@chru-lille.fr>

Insights

This survey of European neonatal units found antenatal steroid and surfactant use aligned with recommendations for very preterm newborns. However, postnatal steroid utilization practices require further clarification.

Area of Science:

  • Neonatal Medicine
  • Pediatric Pulmonology
  • Clinical Practice Surveys

Context:

  • Pulmonary morbidity significantly impacts outcomes for very preterm infants.
  • Variations in clinical practices can influence infant health.
  • A comprehensive understanding of current treatment strategies is essential.

Purpose:

  • To survey current practices in 14 European countries regarding the prevention and treatment of pulmonary morbidity in very preterm newborns.
  • To describe strategies employed for managing respiratory complications in this vulnerable population.
  • To compare surveyed practices with evidence-based recommendations.

Summary:

  • A survey of neonatal units across 14 European countries was conducted using questionnaires on prenatal steroids, surfactant, and postnatal steroids.
  • Results indicate that antenatal steroid administration and surfactant prescription generally adhere to recommended guidelines.
  • Utilization patterns for postnatal steroids were found to be less clearly defined in the surveyed units.

Impact:

  • Identifies adherence to best practices for antenatal steroids and surfactant in very preterm infants.
  • Highlights areas of suboptimal or unclear practice regarding postnatal steroid use.
  • Provides a benchmark for evaluating and improving respiratory care strategies for extremely premature neonates.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...